Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 01/21/2022

Closing price: 68.51

Support price level:	$65.08
Resistance price level:	$70.78
Relative strength index (14-day RSI)	23.4
Beta	0.26

The price of this low-beta stock is expected to increase by 0.26% for every 1% increase in the S&P-500.
Volatility is forecast to fall over the next month.
With RSI < 30, GILD is oversold. Odds slightly favor a short-term price reversal.
Price crossed below 50-day moving average this week - a bearish signal.

Low	High	Price as % of Range
$61.40	$73.64	60.3%

200 day	50 day	20 day	10 day
$68.89	$70.52	$71.70	$70.74

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
26.1%	20.2%	22.8%	25.1%

There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than: